Since medetomidine meets the criteria for being very persistent (vP) according to Annex XIII to Regulation (EC) No 1907/2006, treated articles treated with or incorporating medetomidine should be appropriately labelled when placed on the market.
Recital 10, Regulation (EU) 2015/1731
In forcesince 28 Sep 2015